Translation and Clinical Application of Innovative Cell and Immunotherapies
MAZI connects research, development, quality assurance and clinical application. Its aim is to responsibly advance new therapeutic approaches into early-stage clinical trials and subsequently into patient care. Safety, quality and sustainability are at the heart of this process.
Translational Medicine – From Research to Patient Care
MAZI understands translation as a continuous process: new research findings are systematically developed further, scientifically evaluated and gradually advanced towards clinical application. Quality, safety, standardised processes and access to innovative therapies are central to this approach. In this way, MAZI creates the conditions for scientific innovations to benefit patients as rapidly and responsibly as possible.
Clinical Trials in Cell and Immunotherapies
MAZI supports the establishment, implementation and visibility of early-stage clinical trials in cell and immunotherapies at University Medicine Magdeburg. Clinical trials provide patients with access to innovative therapeutic approaches and contribute to the scientific evaluation and further development of new treatment options.
Information on clinical trials currently available at University Medicine Magdeburg can be found in the clinical trials overview.
Services for Patients, Physicians and Researchers
MAZI is aimed at patients, relatives, physicians, clinical trial centres, clinical research staff and pharmaceutical companies.
The center provides information on innovative cell and immunotherapies, clinical trials, translational research and collaboration opportunities at University Medicine Magdeburg.
